Understanding how sex differences affect psychosis in children and adolescents
Sex-Specific Psychosis Biotypes: Informed Data-driven Neurobiological and Genomic Markers for Early Risk Detection
This study is looking at how psychosis shows up differently in boys and girls to help find it earlier and create better treatments, focusing on young people aged 0-20.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11050594 on NIH RePORTER |
What this research studies
This research investigates the differences in how psychosis manifests in boys and girls, focusing on early detection and tailored interventions. By analyzing brain connectivity and genetic markers in a large group of individuals aged 0-20, the study aims to identify distinct subgroups of psychosis that vary by sex. The approach combines advanced data analysis techniques to uncover biological differences that could lead to better treatment strategies. Ultimately, the goal is to improve outcomes for young people at risk of developing psychotic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adolescents aged 0-20 who may be at risk for developing psychotic disorders.
Not a fit: Patients who are older than 20 or those who do not exhibit any risk factors for psychotic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective early detection and personalized treatment options for young individuals at risk of psychosis.
How similar studies have performed: Previous research has shown promise in identifying sex-specific differences in mental health conditions, suggesting that this approach could yield valuable insights.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Iraji, Armin — Georgia State University
- Study coordinator: Iraji, Armin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.